{"FTNT": {"Ticker": "FTNT", "Company": "Fortinet", "Sector": "Information Technology", "Updated": "2022-05-05", "Rating": [{"Date": "2022-05-05", "Rating": "Upgrade", "Organization": "Mizuho", "Rating_Change": "Neutral to Buy", "Target_Change": "$340 to $350"}, {"Date": "2022-03-29", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$364 to $395"}, {"Date": "2022-03-25", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$385 to $355"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["BofA Securities", "Mizuho", "Barclays"], "Price_Target": 366.67}, "IDXX": {"Ticker": "IDXX", "Company": "Idexx Laboratories", "Sector": "Health Care", "Updated": "2022-05-05", "Rating": [{"Date": "2022-05-05", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$550 to $470"}, {"Date": "2022-02-08", "Rating": "Initiated", "Organization": "Atlantic Equities", "Rating_Change": "Overweight", "Target_Change": "$650"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["BofA Securities", "Atlantic Equities"], "Price_Target": 560.0}, "QRVO": {"Ticker": "QRVO", "Company": "Qorvo", "Sector": "Information Technology", "Updated": "2022-05-05", "Rating": [{"Date": "2022-05-05", "Rating": "Resumed", "Organization": "The Benchmark Company", "Rating_Change": "Buy", "Target_Change": "$175 to $152"}, {"Date": "2022-03-28", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Buy to Neutral", "Target_Change": "$138"}, {"Date": "2022-03-03", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$185 to $150"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["The Benchmark Company", "Morgan Stanley", "Goldman"], "Price_Target": 146.67}, "TWTR": {"Ticker": "TWTR", "Company": "Twitter", "Sector": "Communication Services", "Updated": "2022-05-05", "Rating": [{"Date": "2022-05-05", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-04-26", "Rating": "Upgrade", "Organization": "Stifel", "Rating_Change": "Sell to Hold", "Target_Change": "$39 to $54.20"}, {"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Loop Capital", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-04-21", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": "$50"}, {"Date": "2022-04-20", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$41 to $50"}, {"Date": "2022-04-19", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Neutral", "Target_Change": "$48"}, {"Date": "2022-04-14", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Hold to Sell", "Target_Change": ""}, {"Date": "2022-04-14", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2022-04-05", "Rating": "Downgrade", "Organization": "MKM Partners", "Rating_Change": "Buy to Neutral", "Target_Change": "$49"}, {"Date": "2022-03-11", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$35"}, {"Date": "2022-03-01", "Rating": "Initiated", "Organization": "The Benchmark Company", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": "$52 to $45"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Wedbush", "Rating_Change": "Neutral", "Target_Change": "$46 to $42"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Susquehanna", "Rating_Change": "Positive", "Target_Change": "$85 to $50"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Robert W. Baird", "Rating_Change": "Neutral", "Target_Change": "$80 to $46"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$54 to $46"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Oppenheimer", "Rating_Change": "Outperform", "Target_Change": "$80 to $60"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$57 to $59"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$56 to $46"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$79 to $54"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$55 to $40"}, {"Date": "2022-02-11", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Underweight", "Target_Change": "$64 to $34"}], "Score": -0.09, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 22, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Susquehanna", "Piper Sandler", "Loop Capital", "Argus", "Mizuho", "KeyBanc Capital Markets", "Stifel", "Truist", "Rosenblatt", "Deutsche Bank", "BMO Capital Markets", "Morgan Stanley", "MKM Partners", "Oppenheimer", "BofA Securities", "Barclays", "Wedbush", "The Benchmark Company", "Wolfe Research", "Robert W. Baird", "Citigroup"], "Price_Target": 28.27}}